| scholarly article | Q13442814 |
| P50 | author | Yiqiang Zhang | Q59677307 |
| P2093 | author name string | Ke Cheng | |
| Eduardo Marbán | |||
| Konstantinos Malliaras | |||
| Linda Marbán | |||
| Tao-Sheng Li | |||
| Baiming Sun | |||
| Rachel Ruckdeschel Smith | |||
| John Terrovitis | |||
| Hideo Kusuoka | |||
| Noriko Matsushita | |||
| Agnieszka Blusztajn | |||
| P2860 | cites work | Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction | Q22250889 |
| Isolation and partial characterization of the human homologue of Thy-1 | Q24683775 | ||
| Statistical methods for assessing agreement between two methods of clinical measurement | Q26778461 | ||
| The monoclonal antibody AS02 recognizes a protein on human fibroblasts being highly homologous to Thy-1 | Q28283497 | ||
| Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages | Q28306800 | ||
| Identification and functionality of proteomes secreted by rat cardiac stem cells and neonatal cardiomyocytes | Q28573603 | ||
| Adult cardiac stem cells are multipotent and support myocardial regeneration | Q29620122 | ||
| Paracrine mechanisms in adult stem cell signaling and therapy | Q29620571 | ||
| Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction | Q30824170 | ||
| CD31- but Not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation | Q33216802 | ||
| Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial | Q33505911 | ||
| Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue | Q33506639 | ||
| Mesenchymal cells stimulate capillary morphogenesis via distinct proteolytic mechanisms. | Q33753147 | ||
| Magnetic targeting enhances engraftment and functional benefit of iron-labeled cardiosphere-derived cells in myocardial infarction | Q33911038 | ||
| The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. | Q34010010 | ||
| Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair | Q34103630 | ||
| Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial | Q34332467 | ||
| Expansion of human cardiac stem cells in physiological oxygen improves cell production efficiency and potency for myocardial repair | Q34410262 | ||
| Physiological levels of reactive oxygen species are required to maintain genomic stability in stem cells | Q34619983 | ||
| The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art. | Q34978149 | ||
| Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. | Q35050037 | ||
| Human cardiac stem cells | Q35956924 | ||
| Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction | Q36349782 | ||
| A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction | Q36634299 | ||
| Concise review: mesenchymal stromal cells: potential for cardiovascular repair. | Q37206855 | ||
| Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy | Q39864941 | ||
| Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization | Q40641800 | ||
| Monoclonal antibody YB5.B8 identifies the human c-kit protein product. | Q41138789 | ||
| Epitope mapping and functional studies with three monoclonal antibodies to the c-kit receptor tyrosine kinase, YB5.B8, 17F11, and SR-1. | Q41485991 | ||
| Embryonic stem cell therapy of heart failure in genetic cardiomyopathy | Q41853497 | ||
| Cardiospheres Recapitulate a Niche-Like Microenvironment Rich in Stemness and Cell-Matrix Interactions, Rationalizing Their Enhanced Functional Potency for Myocardial Repair | Q42251376 | ||
| Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction | Q42644713 | ||
| Mechanism of improved cardiac function after bone marrow mononuclear cell therapy: role of cardiovascular lineage commitment | Q43084897 | ||
| Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes | Q44710997 | ||
| Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. | Q48414650 | ||
| Analysis of the origin and population dynamics of cardiac progenitor cells in a donor heart model. | Q50701845 | ||
| Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. | Q50981942 | ||
| Lineage commitment and differentiation of T and natural killer lymphocytes in the fetal mouse. | Q51093055 | ||
| Long-term efficacy and safety of the intramyocardial implantation of autologous bone marrow cells for the treatment of ischemic heart disease. | Q53518781 | ||
| Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. | Q53547964 | ||
| Cytokines produced by bone marrow cells can contribute to functional improvement of the infarcted heart by protecting cardiomyocytes from ischemic injury. | Q53628210 | ||
| Adipose tissue-derived stem cells inhibit neointimal formation in a paracrine fashion in rat femoral artery. | Q54707676 | ||
| Assessment of the anti-c-kit monoclonal antibody YB5.B8 in affinity magnetic enrichment of human lung mast cells | Q71614441 | ||
| Isolation and expansion of adult cardiac stem cells from human and murine heart | Q80837204 | ||
| Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction | Q81435055 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 942-953 | |
| P577 | publication date | 2012-03-01 | |
| P1433 | published in | Journal of the American College of Cardiology | Q2984355 |
| P1476 | title | Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells | |
| P478 | volume | 59 |
| Q35205665 | "Second-generation" stem cells for cardiac repair |
| Q26859990 | "String theory" of c-kit(pos) cardiac cells: a new paradigm regarding the nature of these cells that may reconcile apparently discrepant results |
| Q38289941 | A Deep Proteome Analysis Identifies the Complete Secretome as the Functional Unit of Human Cardiac Progenitor Cells |
| Q38403420 | A Regenerative Cardiac Patch Formed by Spray Painting of Biomaterials onto the Heart |
| Q36709832 | A strong regenerative ability of cardiac stem cells derived from neonatal hearts |
| Q41902675 | Activated macrophages as a feeder layer for growth of resident cardiac progenitor cells |
| Q37111498 | Acute preconditioning of cardiac progenitor cells with hydrogen peroxide enhances angiogenic pathways following ischemia-reperfusion injury |
| Q41976027 | Adenosine A2B receptors on cardiac stem cell antigen (Sca)-1-positive stromal cells play a protective role in myocardial infarction. |
| Q57293174 | Adipose-Derived Mesenchymal Stromal Cells Persist in Tissue-Engineered Vocal Fold Replacement in Rabbits |
| Q36212666 | Adult Lung Spheroid Cells Contain Progenitor Cells and Mediate Regeneration in Rodents With Bleomycin-Induced Pulmonary Fibrosis. |
| Q38344723 | Allogeneic cardiac stem cell administration for acute myocardial infarction |
| Q94603780 | Allogeneic cardiosphere-derived cells (CAP-1002) in critically ill COVID-19 patients: compassionate-use case series |
| Q38676947 | Allogeneic cardiosphere-derived cells for myocardial regeneration: current progress and recent results |
| Q38553235 | Allogenic benefit in stem cell therapy: cardiac repair and regeneration |
| Q35099604 | Angiogenesis, cardiomyocyte proliferation and anti-fibrotic effects underlie structural preservation post-infarction by intramyocardially-injected cardiospheres |
| Q48623367 | Antiarrhythmic effect of growth factor-supplemented cardiac progenitor cells in chronic infarcted heart. |
| Q26745841 | Antifibrotic therapies to control cardiac fibrosis |
| Q38411786 | Apelin-13 infusion salvages the peri-infarct region to preserve cardiac function after severe myocardial injury |
| Q38938530 | Arrhythmogenesis: a Roadblock to Cardiac Stem Cell Therapy. |
| Q64271407 | Autologous bone marrow stem cell therapy for patients undergoing coronary artery bypass grafting: A meta-analysis of 14 randomized controlled trials |
| Q42316372 | Autologous c-Kit+ Mesenchymal Stem Cell Injections Provide Superior Therapeutic Benefit as Compared to c-Kit+ Cardiac-Derived Stem Cells in a Feline Model of Isoproterenol-Induced Cardiomyopathy |
| Q35048419 | Beneficial effects of schisandrin B on the cardiac function in mice model of myocardial infarction |
| Q26799556 | Bioengineering and Stem Cell Technology in the Treatment of Congenital Heart Disease |
| Q27347592 | Bioluminescent imaging of genetically selected induced pluripotent stem cell-derived cardiomyocytes after transplantation into infarcted heart of syngeneic recipients |
| Q34304413 | Blood vessel repair and regeneration in the ischaemic heart |
| Q33746101 | Bone marrow cell therapy in cardiovascular disease drives us slowly to a better identification of the active cell component |
| Q43242296 | Bone marrow-derived cell therapy after myocardial infarction |
| Q38214941 | Bone marrow-derived mesenchymal stem cells for the treatment of heart failure |
| Q30557136 | Bone-derived stem cells repair the heart after myocardial infarction through transdifferentiation and paracrine signaling mechanisms |
| Q36747422 | Boosting the pentose phosphate pathway restores cardiac progenitor cell availability in diabetes |
| Q35187257 | COMP-Ang1 Potentiates EPC Treatment of Ischemic Brain Injury by Enhancing Angiogenesis Through Activating AKT-mTOR Pathway and Promoting Vascular Migration Through Activating Tie2-FAK Pathway |
| Q36957018 | Cadaveric cardiosphere-derived cells can maintain regenerative capacity and improve the heart function of cardiomyopathy |
| Q42731327 | Cardiac Cell Tracking with MRI Reporter Genes: Welcoming a New Field |
| Q36146340 | Cardiac Regeneration and Stem Cells. |
| Q38764929 | Cardiac atrial appendage stem cells promote angiogenesis in vitro and in vivo. |
| Q26739750 | Cardiac progenitor cells for heart repair |
| Q38079141 | Cardiac progenitor/stem cells on myocardial infarction or ischemic heart disease: what we have known from current research |
| Q34617472 | Cardiac regeneration using pluripotent stem cells--progression to large animal models. |
| Q38164335 | Cardiac regeneration: current therapies-future concepts |
| Q35995059 | Cardiac regenerative potential of cardiosphere-derived cells from adult dog hearts |
| Q42575668 | Cardiac stem cell therapy and the promise of heart regeneration |
| Q38067273 | Cardiac stem cells and their roles in myocardial infarction |
| Q38673647 | Cardiac stem cells for myocardial regeneration: promising but not ready for prime time |
| Q26825051 | Cardiac stem cells: biology and clinical applications |
| Q39310120 | Cardiac stem cells: translation to human studies. |
| Q27025973 | Cardiac-derived stem cell-based therapy for heart failure: progress and clinical applications |
| Q36602112 | Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart. |
| Q46477394 | Cardiomyogenesis of periodontal ligament-derived stem cells by dynamic tensile strain |
| Q36169471 | Cardiosphere-Derived Cells Facilitate Heart Repair by Modulating M1/M2 Macrophage Polarization and Neutrophil Recruitment |
| Q42278077 | Cardiosphere-Derived Cells Require Endoglin for Paracrine-Mediated Angiogenesis |
| Q41831569 | Cardiosphere-derived cell sheet primed with hypoxia improves left ventricular function of chronically infarcted heart |
| Q58478037 | Cardiosphere-derived cells suppress allogeneic lymphocytes by production of PGE2 acting via the EP4 receptor |
| Q38055511 | Cardiospheres and cardiosphere-derived cells as therapeutic agents following myocardial infarction |
| Q53508391 | Cell Therapies in Cardiomyopathy: Current Status of Clinical Trials. |
| Q57173700 | Cell Therapy for Chronic Limb-Threatening Ischemia: Current Evidence and Future Directions |
| Q26765916 | Cell Therapy in Ischemic Heart Disease: Interventions That Modulate Cardiac Regeneration |
| Q27001159 | Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions |
| Q36162423 | Cell therapy medicinal product regulatory framework in Europe and its application for MSC-based therapy development |
| Q88618933 | Cell therapy trials for heart regeneration - lessons learned and future directions |
| Q36176132 | Cell-based therapy for prevention and reversal of myocardial remodeling |
| Q42547154 | Cells and pumps: Mechanical support and cellular therapy emerge as a realistic alternative to heart transplantation |
| Q38859871 | Cellular Therapy for Heart Failure. |
| Q41619434 | Cellular and molecular characterization of human cardiac stem cells reveals key features essential for their function and safety. |
| Q39410733 | Cellular mechanisms underlying cardiac engraftment of stem cells. |
| Q41888608 | Cellular postconditioning: allogeneic cardiosphere-derived cells reduce infarct size and attenuate microvascular obstruction when administered after reperfusion in pigs with acute myocardial infarction |
| Q28083859 | Challenges in identifying the best source of stem cells for cardiac regeneration therapy |
| Q92820171 | Characterization of human cardiac mesenchymal stromal cells and their extracellular vesicles comparing with human bone marrow derived mesenchymal stem cells |
| Q48653724 | Circulating Exosomes in Cardiovascular Diseases |
| Q36054295 | Comparative Efficacy of Intracoronary Allogeneic Mesenchymal Stem Cells and Cardiosphere-Derived Cells in Swine with Hibernating Myocardium |
| Q27021931 | Concise review: heart regeneration and the role of cardiac stem cells |
| Q35774278 | Contemporary perspective on endogenous myocardial regeneration |
| Q64274926 | Cortical Bone Derived Stem Cells for Cardiac Wound Healing |
| Q42836395 | Cortical bone-derived stem cells: a novel class of cells for myocardial protection |
| Q48601122 | Cryopreservation of canine cardiosphere-derived cells: Implications for clinical application |
| Q38697092 | Current State of Stem Cell Therapy for Ischemic Heart Disease |
| Q38090542 | Current status of cell-based therapy for heart failure |
| Q51420017 | Differential response of human cardiac stem cells and bone marrow mesenchymal stem cells to hypoxia-reoxygenation injury. |
| Q48033062 | Distinct patterns of histone modifications at cardiac-specific gene promoters between cardiac stem cells and mesenchymal stem cells |
| Q33798113 | Dnmt3a-mediated inhibition of Wnt in cardiac progenitor cells improves differentiation and remote remodeling after infarction. |
| Q37591405 | Dose-dependency and reversibility of radiation-induced injury in cardiac explant-derived cells of mice |
| Q36714104 | Durable Benefits of Cellular Postconditioning: Long-Term Effects of Allogeneic Cardiosphere-Derived Cells Infused After Reperfusion in Pigs with Acute Myocardial Infarction. |
| Q34467911 | Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial |
| Q36930496 | Effects of Matrix Metalloproteinases on the Performance of Platelet Fibrin Gel Spiked With Cardiac Stem Cells in Heart Repair |
| Q40301895 | Electrical effects of stem cell transplantation for ischaemic cardiomyopathy: friend or foe? |
| Q38178645 | Endogenous cardiac stem cells for the treatment of heart failure |
| Q92511363 | Enhanced Immunomodulation in Inflammatory Environments Favors Human Cardiac Mesenchymal Stromal-Like Cells for Allogeneic Cell Therapies |
| Q96132624 | Exosomal lncRNA AK139128 Derived from Hypoxic Cardiomyocytes Promotes Apoptosis and Inhibits Cell Proliferation in Cardiac Fibroblasts |
| Q38304096 | Exosome and its roles in cardiovascular diseases |
| Q55002268 | Exosome-Mediated Benefits of Cell Therapy in Mouse and Human Models of Duchenne Muscular Dystrophy. |
| Q40477633 | Exosomes as critical agents of cardiac regeneration triggered by cell therapy. |
| Q92350036 | Expansion Culture of Human Pluripotent Stem Cells and Production of Cardiomyocytes |
| Q34343125 | Fused X-ray and MR imaging guidance of intrapericardial delivery of microencapsulated human mesenchymal stem cells in immunocompetent swine |
| Q26865425 | Gene and cell therapies for the failing heart to prevent sudden arrhythmic death |
| Q38783991 | Generation of clinical-grade functional cardiomyocytes from human embryonic stem cells in chemically defined conditions |
| Q39136745 | Generation of induced cardiac progenitor cells via somatic reprogramming |
| Q34525560 | Global intracoronary infusion of allogeneic cardiosphere-derived cells improves ventricular function and stimulates endogenous myocyte regeneration throughout the heart in swine with hibernating myocardium |
| Q93197900 | Healing the Broken Heart; The Immunomodulatory Effects of Stem Cell Therapy |
| Q42628519 | Heart Repair Using Nanogel-Encapsulated Human Cardiac Stem Cells in Mice and Pigs with Myocardial Infarction. |
| Q89870117 | Heart regeneration in mouse and human: A bioengineering perspective |
| Q41376683 | Heart-Derived Stem Cells in Miniature Swine with Coronary Microembolization: Novel Ischemic Cardiomyopathy Model to Assess the Efficacy of Cell-Based Therapy. |
| Q36995578 | Hiding inside? Intracellular expression of non-glycosylated c-kit protein in cardiac progenitor cells |
| Q26865608 | Highlights of the year in JACC 2012 |
| Q41627465 | Histone Deacetylase 1 Depletion Activates Human Cardiac Mesenchymal Stromal Cell Proangiogenic Paracrine Signaling Through a Mechanism Requiring Enhanced Basic Fibroblast Growth Factor Synthesis and Secretion |
| Q47144816 | Human Cardiac-Derived Stem/Progenitor Cells Fine-Tune Monocyte-Derived Descendants Activities toward Cardiac Repair |
| Q37355739 | Human blood and cardiac stem cells synergize to enhance cardiac repair when cotransplanted into ischemic myocardium. |
| Q37557881 | Human cardiosphere-derived cells from advanced heart failure patients exhibit augmented functional potency in myocardial repair |
| Q36247715 | Human cardiosphere-derived cells from patients with chronic ischaemic heart disease can be routinely expanded from atrial but not epicardial ventricular biopsies |
| Q36882814 | Human cardiospheres as a source of multipotent stem and progenitor cells |
| Q98196692 | Human pluripotent stem cell-derived cardiomyocytes as a target platform for paracrine protection by cardiac mesenchymal stromal cells |
| Q37171447 | Human vasculogenic cells form functional blood vessels and mitigate adverse remodeling after ischemia reperfusion injury in rats |
| Q37165628 | Hyaluronic acid-serum hydrogels rapidly restore metabolism of encapsulated stem cells and promote engraftment. |
| Q37383576 | Image-guided therapies for myocardial repair: concepts and practical implementation |
| Q34066995 | Importance of cell-cell contact in the therapeutic benefits of cardiosphere-derived cells |
| Q26771255 | Improving Cell Engraftment in Cardiac Stem Cell Therapy |
| Q37409993 | Increasing injection frequency enhances the survival of injected bone marrow derived mesenchymal stem cells in a critical limb ischemia animal model |
| Q36656969 | Influence of aging on the quantity and quality of human cardiac stem cells |
| Q28116477 | Inhibitory effect of hsa-miR-590-5p on cardiosphere-derived stem cells differentiation through downregulation of TGFB signaling |
| Q53599953 | Interleukin-6 contributes to the paracrine effects of cardiospheres cultured from human, murine and rat hearts. |
| Q41247871 | Intracoronary allogeneic cardiosphere-derived stem cells are safe for use in dogs with dilated cardiomyopathy. |
| Q29620043 | Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial |
| Q92151245 | Intravascular Stem Cell Bioreactor for Prevention of Adverse Remodeling After Myocardial Infarction |
| Q64967429 | Ion Therapy: A Novel Strategy for Acute Myocardial Infarction. |
| Q36713333 | Isolation, Characterization, and Spatial Distribution of Cardiac Progenitor Cells in the Sheep Heart |
| Q99238015 | Large Animal Models in Regenerative Medicine and Tissue Engineering: To Do or Not to Do |
| Q90632714 | Letter by Ibrahim et al Regarding Article, "Lack of Cardiac Improvement After Cardiosphere-Derived Cell Transplantation in Aging Mouse Hearts" |
| Q36198168 | Lysophospholipids in coronary artery and chronic ischemic heart disease |
| Q38124756 | Mechanistic molecular imaging of cardiac cell therapy for ischemic heart disease |
| Q47146529 | Mesenchymal Stem Cells in Cardiology |
| Q30896351 | Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data |
| Q37611026 | Metformin promotes the survival of transplanted cardiosphere-derived cells thereby enhancing their therapeutic effect against myocardial infarction |
| Q94452130 | Microencapsulated Insulin-Like Growth Factor-1 therapy improves cardiac function and reduces fibrosis in a porcine acute myocardial infarction model |
| Q27026108 | Molecular characterization of heterogeneous mesenchymal stem cells with single-cell transcriptomes |
| Q38183144 | Multipotent (adult) and pluripotent stem cells for heart regeneration: what are the pros and cons? |
| Q36014092 | Myocardial repair and regeneration: bone marrow or cardiac stem cells? |
| Q58595535 | NIPAM-based Microgel Microenvironment Regulates the Therapeutic Function of Cardiac Stromal Cells |
| Q30837375 | Obtaining spontaneously beating cardiomyocyte-like cells from adipose-derived stromal vascular fractions cultured on enzyme-crosslinked gelatin hydrogels |
| Q42558687 | Osteogenic potential of sorted equine mesenchymal stem cell subpopulations |
| Q35775407 | PDGFRα demarcates the cardiogenic clonogenic Sca1+ stem/progenitor cell in adult murine myocardium |
| Q38204262 | Paracrine effects of stem cells in wound healing and cancer progression (Review). |
| Q37241166 | Pathological ventricular remodeling: mechanisms: part 1 of 2 |
| Q34785250 | Percutaneous intramyocardial delivery of mesenchymal stem cells induces superior improvement in regional left ventricular function compared with bone marrow mononuclear cells in porcine myocardial infarcted heart |
| Q36437708 | Perspectives on the Evolution of Stem Cell Therapy for Heart Failure |
| Q91634716 | Platelet-Inspired Nanocells for Targeted Heart Repair After Ischemia/Reperfusion Injury |
| Q37016190 | Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure |
| Q39069601 | Possible Muscle Repair in the Human Cardiovascular System |
| Q33722072 | Potency of Human Cardiosphere-Derived Cells from Patients with Ischemic Heart Disease Is Associated with Robust Vascular Supportive Ability |
| Q27012551 | Potential of cardiac stem/progenitor cells and induced pluripotent stem cells for cardiac repair in ischaemic heart disease |
| Q38989011 | Proceedings: Moving Toward Cell-Based Therapies for Heart Disease |
| Q52645924 | Qualitative and Quantitative Analysis of Cardiac Progenitor Cells in Cases of Myocarditis and Cardiomyopathy. |
| Q97527342 | Quantitative Hybrid Cardiac [18F]FDG-PET-MRI Images for Assessment of Cardiac Repair by Preconditioned Cardiosphere-Derived Cells |
| Q33583711 | RETRACTED: Cardioprotective activity of placental growth factor in a rat model of acute myocardial infarction: nanoparticle-based delivery versus direct myocardial injection |
| Q35626702 | Recent advances in the diagnosis and treatment of acute myocardial infarction |
| Q33909634 | Recruitment and retention of human autologous CD34+ CD117+ CD133+ bone marrow stem cells to infarcted myocardium followed by directed vasculogenesis: Novel strategy for cardiac regeneration |
| Q34399774 | Regenerative medicine for the heart: perspectives on stem-cell therapy |
| Q64970281 | Regenerative therapies in young hearts with structural or congenital heart disease. |
| Q35070840 | Relative roles of CD90 and c-kit to the regenerative efficacy of cardiosphere-derived cells in humans and in a mouse model of myocardial infarction |
| Q38659518 | Renal Tubular Cell-Derived Extracellular Vesicles Accelerate the Recovery of Established Renal Ischemia Reperfusion Injury |
| Q50133309 | Response by Marbán and de Couto to Letter Regarding Article, "Exosomal MicroRNA Transfer Into Macrophages Mediates Cellular Postconditioning". |
| Q64937621 | Role of Macrophages in Cardioprotection. |
| Q34123206 | Role of adenosine A2B receptor signaling in contribution of cardiac mesenchymal stem-like cells to myocardial scar formation. |
| Q37724023 | Serum and supplement optimization for EU GMP-compliance in cardiospheres cell culture |
| Q47104911 | Sex Differences of Human Cardiac Progenitor Cells in the Biological Response to TNF-α Treatment. |
| Q38098219 | Stem cell stimulation of endogenous myocyte regeneration |
| Q38239132 | Stem cell therapies in patients with single ventricle physiology |
| Q26786034 | Stem cell therapy for CHD: towards translation |
| Q34129904 | Stem cell therapy for cardiac dysfunction |
| Q30239945 | Stem cell therapy for chronic ischaemic heart disease and congestive heart failure. |
| Q90020213 | Stem cell therapy: old challenges and new solutions |
| Q38158218 | Stem cells for cardiac repair: problems and possibilities |
| Q28082047 | Stem cells for the treatment of heart failure |
| Q42587066 | Stem cells on a new stage: Treatment of hypoplastic left heart syndrome |
| Q57767168 | Stem-Cell-Based Therapies for Vascular Regeneration in Peripheral Artery Diseases |
| Q34372277 | Stimulation of endogenous cardioblasts by exogenous cell therapy after myocardial infarction |
| Q47926132 | Sub-physiological oxygen levels optimal for growth and survival of human atrial cardiac stem cells |
| Q37603820 | Sustained delivery of insulin-like growth factor-1/hepatocyte growth factor stimulates endogenous cardiac repair in the chronic infarcted pig heart. |
| Q47282040 | Synergistic role of 5-azacytidine and ascorbic acid in directing cardiosphere derived cells to cardiomyocytes in vitro by downregulating Wnt signaling pathway via phosphorylation of β-catenin. |
| Q55382872 | TGF-β1/CD105 signaling controls vascular network formation within growth factor sequestering hyaluronic acid hydrogels. |
| Q42031459 | TGFβ-dependent epithelial-to-mesenchymal transition is required to generate cardiospheres from human adult heart biopsies |
| Q88967545 | Targeted repair of heart injury by stem cells fused with platelet nanovesicles |
| Q57169628 | The Biological Mechanisms of Action of Cardiac Progenitor Cell Therapy |
| Q26769042 | The Evolution of the Stem Cell Theory for Heart Failure |
| Q37328786 | The advancing field of cell-based therapy: insights and lessons from clinical trials. |
| Q47871137 | The atrial appendage as a suitable source to generate cardiac-derived adherent proliferating cells for regenerative cell-based therapies. |
| Q46302230 | The current status and future of cardiac stem/progenitor cell therapy for congenital heart defects from diabetic pregnancy |
| Q38375149 | The duality of chemokines in heart failure |
| Q37625460 | The existence of myocardial repair: mechanistic insights and enhancements |
| Q37328729 | The origin of human mesenchymal stromal cells dictates their reparative properties. |
| Q34634535 | The relative contribution of paracine effect versus direct differentiation on adipose-derived stem cell transplantation mediated cardiac repair |
| Q48103647 | The role of β-adrenergic receptors and p38MAPK signaling pathways in physiological processes of cardiosphere-derived cells. |
| Q28081476 | The winding road to regenerating the human heart |
| Q38191829 | Therapeutic application of adipose derived stem cells in acute myocardial infarction: lessons from animal models |
| Q41512469 | Therapeutic benefits of intravenous cardiosphere-derived cell therapy in rats with pulmonary hypertension |
| Q35203566 | Therapeutic efficacy of cardiosphere-derived cells in a transgenic mouse model of non-ischaemic dilated cardiomyopathy |
| Q33908373 | Therapeutic microparticles functionalized with biomimetic cardiac stem cell membranes and secretome |
| Q28076187 | Therapeutic use of stem cells for cardiovascular disease |
| Q37745324 | Thermosensitive and Highly Flexible Hydrogels Capable of Stimulating Cardiac Differentiation of Cardiosphere-Derived Cells under Static and Dynamic Mechanical Training Conditions |
| Q34041000 | Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience |
| Q52729630 | Translational cardiac stem cell therapy: advancing from first-generation to next-generation cell types. |
| Q26774565 | Translational research of adult stem cell therapy |
| Q52963392 | Transplantation of adipose tissue-derived stem cells improves cardiac contractile function and electrical stability in a rat myocardial infarction model. |
| Q55006691 | Trophic effects of adipose-tissue-derived and bone-marrow-derived mesenchymal stem cells enhance cartilage generation by chondrocytes in co-culture. |
| Q36504336 | iPSC-derived human cardiac progenitor cells improve ventricular remodelling via angiogenesis and interstitial networking of infarcted myocardium |
| Q53278758 | mAb C19 targets a novel surface marker for the isolation of human cardiac progenitor cells from human heart tissue and differentiated hESCs. |
| Q37411881 | Β-blockers treatment of cardiac surgery patients enhances isolation and improves phenotype of cardiosphere-derived cells. |
Search more.